Industry Briefs

A 12-member group of chemical companies that produces chlorofluorocarbons is stepping up efforts to investigate the environmental impact of their alternative: hydrochloro- fluorocarbons and hydrofluorocarbons. They are hoping that this research will confirm their initial findings, presented at the United Nations Environment Programme in Nairobi last year, that these alternatives have little significant environmental impact, unlike chlorofluorocarbons, which have been implicated in the destructi

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A 12-member group of chemical companies that produces chlorofluorocarbons is stepping up efforts to investigate the environmental impact of their alternative: hydrochloro- fluorocarbons and hydrofluorocarbons. They are hoping that this research will confirm their initial findings, presented at the United Nations Environment Programme in Nairobi last year, that these alternatives have little significant environmental impact, unlike chlorofluorocarbons, which have been implicated in the destruction of the earth's atmospheric ozone and face a worldwide ban. The group will sponsor $6 million in research at university, government, and independent laboratories over the next three years, while funding a comparable amount for internal research on atmospheric science. Faced with criticism of the long-term use of these replacement chemicals, the companies hope to convince environmentalists and their governments that the chemicals are safe - and to give them guarantees that they will be allowed to sell them long enough to recoup their investments.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies